Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-Controlled, Double-Blind 13-Week Study to Evaluate the Safety, Tolerability, and Weight Loss Efficacy of K-757 Alone and in Combination With K-833 in Participants Who Are Obese

NCT06019559 is registered in ClinicalTrials.gov with Kallyope Inc. as lead sponsor.

NCT NCT06019559
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06019559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-Controlled, Double-Blind 13-Week Study to Evaluate the Safety, Tolerability, and Weight Loss Efficacy of K-757 Alone and in Combination With K-833 in Participants Who Are Obese
Lead sponsor
Kallyope Inc.
Phase
Phase 2
Overall status
Completed
Start date
September 15, 2023
Completion date
February 19, 2024
Enrollment
155 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

obesity